NIAID Archives - EverGlade

NIAID

A Closer Look at the NIH and DoW Medical Countermeasure Agreement

Leave a Comment / All Posts, Defense, Industry News, Life Sciences, NIAID / By

Earlier this month, on September 4, the The National Institutes of Health (NIH) and the United States Department of War (DoW) released a 10-year interagency agreement (IAA) supporting the advanced development of medical countermeasures for pandemic influenza, chemical, biological, radiological, and nuclear threats, and emerging infectious diseases. The agreement brings NIH’s scientific data, product pipelines,

A Closer Look at the NIH and DoW Medical Countermeasure Agreement Read More »

NIAID Renews IMPAc‑TB to Accelerate Tuberculosis Vaccine Development 

Leave a Comment / All Posts, Life Sciences, NIAID / By

Overview of the Opportunity The National Institute of Allergy and Infectious Diseases (NIAID), through the National Institutes of Health (NIH), has issued RFP No. BAA-75N93026R00008 for the Immune Mechanisms of Protection Against Mycobacterium tuberculosis Center (IMPAc‑TB), a five‑year contract program that renews the effort to accelerate TB vaccine development. The goal is to define tissue‑specific and

NIAID Renews IMPAc‑TB to Accelerate Tuberculosis Vaccine Development  Read More »

pSMILE Program RFP

Advancing Global Laboratory Quality Through NIAID’s pSMILE Program

Leave a Comment / Life Sciences, NIAID / By

pSMILE RFP_75N93025R00011 with Attachments The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has released a new Request for Proposals (RFP) for the Patient Safety Monitoring in International Laboratories (pSMILE) program. Issued by NIAID’s Office of Acquisitions, this solicitation seeks to strengthen the quality, reliability, and regulatory

Advancing Global Laboratory Quality Through NIAID’s pSMILE Program Read More »

Radiation & Nuclear Medical Countermeasures (MCMs) and Biodosimetry Devices

Development of Radiation/Nuclear Medical Countermeasures And Biodosimetry Devices

Leave a Comment / All Posts, Life Sciences, NIAID / By

NIAID_Presolicitation_Notice_Rad_Nuc MCMs Overview of Solicitation The National Institute of Allergy and Infectious Diseases (NIAID), under the National Institutes of Health (NIH), has released a pre-solicitation notice for the development of Radiation/Nuclear Medical Countermeasures (MCMs) and Biodosimetry Devices. This Broad Agency Announcement (BAA 75N93024R00020) is an invitation for innovators in the critical field of radiation emergency

Development of Radiation/Nuclear Medical Countermeasures And Biodosimetry Devices Read More »

medical countermeasures for biodefense and infectious diseases

Omnibus Solicitation Seeks Medical Countermeasures for Biodefense and Emerging Infectious Disease

Leave a Comment / All Posts, Life Sciences, NIAID / By

HHS-NIH-NIAID-BAA2025-1 The U.S. Department of Health and Human Services (HHS), through the National Institutes of Health (NIH) and the National Institute of Allergy and Infectious Diseases (NIAID), has released the Broad Agency Announcement (BAA) HHS-NIH-NIAID-BAA2025-1. This announcement presents an exciting opportunity for researchers, organizations, and industry leaders to contribute to critical biomedical and biodefense initiatives.

Omnibus Solicitation Seeks Medical Countermeasures for Biodefense and Emerging Infectious Disease Read More »

antimicrobial-resistant (AMR) pathogens and viruses

NIAID Omnibus Broad Agency Announcement (BAA)

Leave a Comment / All Posts, Life Sciences, NIAID / By

Pre-solicitation_Notice_-_BAA2025-1_Final Overview of Solicitation The upcoming 2026 Omnibus Broad Agency Announcement (BAA) is from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH) under the Department of Health and Human Services (DHHS). NIAID’s mission centers on understanding, treating, and preventing infectious, immunologic, and allergic diseases. Through

NIAID Omnibus Broad Agency Announcement (BAA) Read More »

NIH Funding

New NIH Funding Opportunity – Investigating the Role of Genomic Variation on Gene Regulation and Disease

Leave a Comment / All Posts, Life Sciences, NIAID / By

At EverGlade, we are always on the lookout for new funding opportunities that can help our clients advance their research and development goals. Today, we’re excited to inform you about a new Request for Applications (RFA) from the National Institutes of Health (NIH): RFA-HG-24-004.

New NIH Funding Opportunity – Investigating the Role of Genomic Variation on Gene Regulation and Disease Read More »

Scientist with test tubes for NIAID Funding Guide

A Guide to NIAID Funding

Leave a Comment / All Posts, Guides, Life Sciences, NIAID / By

A Guide to NIAID Funding: Application Process, Financial and Technical Requirements The National Institute of Allergy and Infectious Diseases (NIAID) is a part of the U.S. National Institutes of Health (NIH), focusing on research related to infectious, immunologic, and allergic diseases. Securing NIAID funding can be a significant milestone for researchers and organizations in these

A Guide to NIAID Funding Read More »

Scroll to Top